OPG has previously been described as a CV marker for all-cause death in HD patients [22,23,24], and TRAIL-R2 is present in human atherosclerotic lesions with higher expression levels in vulnerable plaques than in stable ones [25]. The gene discussed is TNFRSF10B; the disease is Huntington disease.